Roche (RHHBY) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free RHHBY Stock Alerts $30.02 -0.52 (-1.70%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider TradesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRoche Holding AG (OTCMKTS:RHHBY) Shares Sold by Meritage Portfolio Managementmarketbeat.com - April 25 at 5:33 PMVividion Therapeutics and Roche Jointly Publish Landmark Nature Paper on Clinical-Stage Covalent Allosteric Inhibitor of Werner Helicase (WRN)businesswire.com - April 25 at 7:00 AMRoche Holding AG (OTCMKTS:RHHBY) Given Consensus Rating of "Hold" by Analystsamericanbankingnews.com - April 25 at 1:22 AMRoche cuts drug pipeline in effort to revitalise businessft.com - April 24 at 4:02 PMHookipa Received FDA Clearance For HB-700 For Treatment Of KRAS-Mutated Cancersmarkets.businessinsider.com - April 24 at 11:01 AMWhy Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?benzinga.com - April 24 at 11:01 AMRoche Q1 Group Sales Down 6%; Confirms 2024 Outlook - Quick Factsmarkets.businessinsider.com - April 24 at 5:06 AMSwiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slumpcnbc.com - April 24 at 1:58 AMRoche Q1 sales down 6% on forex effect, loss of COVID revenuereuters.com - April 24 at 1:14 AM[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19globenewswire.com - April 24 at 1:00 AMPharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Datamsn.com - April 19 at 3:11 PMF. Hoffmann-La Roche Ltd: FDA approves Roche's Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancerfinanznachrichten.de - April 19 at 3:29 AMFDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancerfinance.yahoo.com - April 19 at 3:29 AMRoche Announces FDA Approval For Alecensamarkets.businessinsider.com - April 19 at 3:29 AMFDA approves Roche's Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancerglobenewswire.com - April 19 at 1:00 AMFDA Approves Genentech's Alecensa For ALK-positive Early-Stage Lung Cancermarkets.businessinsider.com - April 18 at 10:08 PMFDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancerbusinesswire.com - April 18 at 4:35 PMGenentech’s Subcutaneous Ocrevus One-Year Data Demonstrates Near-Complete Suppression of Clinical Relapses and Brain Lesions in Patients With Progressive and Relapsing Forms of MSfinance.yahoo.com - April 17 at 10:38 AMCelebration Obstetrics & Gynecology Now Accepting Partner's Direct Health Insurancefinance.yahoo.com - April 16 at 1:44 PMRoche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patientsmsn.com - April 15 at 3:19 PMGenentech's Columvi Meets Primary Endpoint of Overall Survival in People With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Phase III STARGLO Studybusinesswire.com - April 15 at 1:10 AM[Ad hoc announcement pursuant to Art. 53 LR] Roche's Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO studyglobenewswire.com - April 15 at 1:00 AMGuru Fundamental Report for RHHBYnasdaq.com - April 13 at 12:02 AMWhy Roche Holdings Stock Popped Todayfool.com - April 11 at 6:33 PMF. Hoffmann-La Roche Ltd: Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosisfinanznachrichten.de - April 11 at 9:52 AMRoche's Elecsys PTau217 Blood Test Receives FDA Breakthrough Designation For Alzheimer's Detectionmarkets.businessinsider.com - April 11 at 9:52 AMRoche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosisglobenewswire.com - April 11 at 1:00 AMRoche Gets CE Mark For First Companion Diagnostic To Identify HER2-low Metastatic Breast Cancermarkets.businessinsider.com - April 10 at 9:06 AMRoche companion diagnostic test wins CE Mark to identify metastatic breast cancer patientsmsn.com - April 10 at 9:06 AMRoche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTUprnewswire.com - April 10 at 1:00 AMMeet Europe's Mag 18. Novo Nordisk Stock, ASML, and Others Can Rival the Mag Seven.barrons.com - April 9 at 11:42 AMVeracode Embarks on a New Chapter with Appointment of Brian Roche as Chief Executive Officerbusinesswire.com - April 3 at 12:36 PMF. Hoffmann-La Roche Ltd: Roche receives FDA approval for the first molecular test to screen for malaria in blood donorsfinanznachrichten.de - March 27 at 10:19 AMRoche receives FDA approval for the first molecular test to screen for malaria in blood donorsglobenewswire.com - March 26 at 12:45 PMHot Stocks: The 3 Best Opportunities for Investing in Weight Loss Drugsinvestorplace.com - March 22 at 5:07 PMRoche (OTCMKTS:RHHBY) Reaches New 1-Year Low at $31.16marketbeat.com - March 21 at 8:19 PMSwiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2Bmsn.com - March 20 at 3:50 PMLonza to buy U.S. biologics site from Roche for $1.2Bmsn.com - March 20 at 7:11 AMBoston Common Asset Management LLC Sells 55,260 Shares of Roche Holding AG (OTCMKTS:RHHBY)marketbeat.com - March 16 at 4:08 PMRoche Holding AG (RHHBY)uk.finance.yahoo.com - March 15 at 1:58 PMCatalyst announces US launch of Duchenne drug Agamreemsn.com - March 13 at 3:12 PMRoche Holding AG's Dividend Analysisfinance.yahoo.com - March 13 at 8:38 AMRoche Annual General Meeting 2024globenewswire.com - March 12 at 8:30 AMRoche showcases new navify® digital solutions that generate operational insights for faster decision-making in diagnostics at HIMSS¹ 2024prnewswire.com - March 12 at 2:00 AMKronos cuts 21% of workforce, extends cash runway into 2H 2026msn.com - March 7 at 7:27 PMRamirez Asset Management Inc. Takes $2.58 Million Position in Roche Holding AG (OTCMKTS:RHHBY)marketbeat.com - March 7 at 11:26 AMRoche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of careglobenewswire.com - March 5 at 7:30 AMRoche just downgraded at Argus, here's whyrealmoney.thestreet.com - March 4 at 2:19 PMRoche explores selling lung disease drug, Bloomberg reportsreuters.com - February 26 at 11:54 AMRoche: Strong Long-Term Potential Overshadowedseekingalpha.com - February 26 at 9:45 AM Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> RHHBY Media Mentions By Week RHHBY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RHHBY News Sentiment▼0.250.41▲Average Medical News Sentiment RHHBY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RHHBY Articles This Week▼164▲RHHBY Articles Average Week Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bayer Aktiengesellschaft News Capstone News Context Therapeutics News EOM Pharmaceuticals News Genmab A/S News Grifols News Hypera News International Stem Cell News LAVA Therapeutics News Mainz Biomed News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RHHBY) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roche Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
